Elyse Katz

1.9k total citations
15 papers, 1.4k citations indexed

About

Elyse Katz is a scholar working on Cognitive Neuroscience, Psychiatry and Mental health and Physiology. According to data from OpenAlex, Elyse Katz has authored 15 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cognitive Neuroscience, 5 papers in Psychiatry and Mental health and 4 papers in Physiology. Recurrent topics in Elyse Katz's work include Dementia and Cognitive Impairment Research (5 papers), Alzheimer's disease research and treatments (4 papers) and Functional Brain Connectivity Studies (4 papers). Elyse Katz is often cited by papers focused on Dementia and Cognitive Impairment Research (5 papers), Alzheimer's disease research and treatments (4 papers) and Functional Brain Connectivity Studies (4 papers). Elyse Katz collaborates with scholars based in United States, United Kingdom and Canada. Elyse Katz's co-authors include Helen S. Mayberg, Timothy E.J. Behrens, Matthew F. S. Rushworth, David A. Gutman, Paul M. Matthews, Andrés M. Lozano, Heidi Johansen‐Berg, Sanjaya Saxena, Karron M. Maidment and Erlyn Smith and has published in prestigious journals such as PLoS ONE, NeuroImage and American Journal of Psychiatry.

In The Last Decade

Elyse Katz

15 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elyse Katz United States 10 525 307 269 237 184 15 1.4k
Hongjun Tian China 22 435 0.8× 309 1.0× 241 0.9× 136 0.6× 93 0.5× 117 1.7k
Suzanne Reeves United Kingdom 26 588 1.1× 708 2.3× 185 0.7× 332 1.4× 232 1.3× 81 1.9k
Diana Truran United States 18 507 1.0× 493 1.6× 106 0.4× 326 1.4× 113 0.6× 37 1.5k
Matteo De Marco United Kingdom 20 584 1.1× 445 1.4× 103 0.4× 252 1.1× 184 1.0× 71 1.3k
María Luisa Soto‐Montenegro Spain 24 383 0.7× 342 1.1× 75 0.3× 178 0.8× 167 0.9× 78 1.6k
Alberto Marcos Spain 23 669 1.3× 384 1.3× 69 0.3× 330 1.4× 205 1.1× 65 1.5k
Charles B. Malpas Australia 25 435 0.8× 712 2.3× 193 0.7× 249 1.1× 254 1.4× 129 1.8k
Frank Faltraco Germany 22 409 0.8× 491 1.6× 106 0.4× 423 1.8× 97 0.5× 41 1.6k
Anand Kumar India 19 433 0.8× 482 1.6× 72 0.3× 228 1.0× 164 0.9× 107 1.5k
Maria A. Di Biase Australia 19 561 1.1× 294 1.0× 107 0.4× 97 0.4× 128 0.7× 47 1.3k

Countries citing papers authored by Elyse Katz

Since Specialization
Citations

This map shows the geographic impact of Elyse Katz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elyse Katz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elyse Katz more than expected).

Fields of papers citing papers by Elyse Katz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elyse Katz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elyse Katz. The network helps show where Elyse Katz may publish in the future.

Co-authorship network of co-authors of Elyse Katz

This figure shows the co-authorship network connecting the top 25 collaborators of Elyse Katz. A scholar is included among the top collaborators of Elyse Katz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elyse Katz. Elyse Katz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Asrani, Sumeet K., Russell H. Wiesner, J.F. Trotter, et al.. (2014). De Novo Sirolimus and Reduced-Dose Tacrolimus Versus Standard-Dose Tacrolimus After Liver Transplantation: The 2000–2003 Phase II Prospective Randomized Trial. American Journal of Transplantation. 14(2). 356–366. 60 indexed citations
3.
Katz, Elyse, Emily Carrier, Craig A. Umscheid, & Jesse M. Pines. (2012). Comparative Effectiveness of Care Coordination Interventions in the Emergency Department: A Systematic Review. Annals of Emergency Medicine. 60(1). 12–23.e1. 91 indexed citations
4.
Jedynak, Bruno, Andrew Lang, Bo Liu, et al.. (2012). A computational neurodegenerative disease progression score: Method and results with the Alzheimer's disease neuroimaging initiative cohort. NeuroImage. 63(3). 1478–1486. 166 indexed citations
5.
Sukkar, R.A., Elyse Katz, Yanwei Zhang, David Raunig, & Bradley T. Wyman. (2012). Disease progression modeling using Hidden Markov Models. PubMed. 2012. 2845–2848. 48 indexed citations
6.
Jedynak, Bruno, Bo Liu, Andrew Lang, et al.. (2012). O4‐01‐06: Sample size comparisons in ADNI: A case for the Alzheimer's Disease Progression Scale. Alzheimer s & Dementia. 8(4S_Part_17). 2 indexed citations
7.
Hu, Xiaolan, Eve H. Pickering, Sara Hall, et al.. (2011). Genome-wide association study identifies multiple novel loci associated with disease progression in subjects with mild cognitive impairment. Translational Psychiatry. 1(11). e54–e54. 30 indexed citations
8.
Hu, Xiaolan, Eve H. Pickering, Hélène Fournier, et al.. (2011). Meta-Analysis for Genome-Wide Association Study Identifies Multiple Variants at the BIN1 Locus Associated with Late-Onset Alzheimer's Disease. PLoS ONE. 6(2). e16616–e16616. 124 indexed citations
9.
Sukkar, R.A., Bradley T. Wyman, Elyse Katz, Yanwei Zhang, & David Raunig. (2011). P1‐118: Modeling Alzheimer's disease progression using hidden markov models. Alzheimer s & Dementia. 7(4S_Part_4). 2 indexed citations
10.
Comery, Thomas A., Kenneth Zasadny, Evan D. Morris, et al.. (2011). P4‐253: Receptor occupancy of the 5‐HT6 receptor antagonist SAM‐760 in non‐human primates and healthy human volunteers. Alzheimer s & Dementia. 7(4S_Part_23). 1 indexed citations
11.
Ito, Kaori, Brian Corrigan, Qinying Zhao, et al.. (2010). Disease progression model for cognitive deterioration from Alzheimer's Disease Neuroimaging Initiative database. Alzheimer s & Dementia. 7(2). 151–160. 108 indexed citations
12.
Chen, Philip E., Matthew T. Geballe, Elyse Katz, et al.. (2007). Modulation of glycine potency in rat recombinant NMDA receptors containing chimeric NR2A/2D subunits expressed inXenopus laevisoocytes. The Journal of Physiology. 586(1). 227–245. 76 indexed citations
13.
Johansen‐Berg, Heidi, David A. Gutman, Timothy E.J. Behrens, et al.. (2007). Anatomical Connectivity of the Subgenual Cingulate Region Targeted with Deep Brain Stimulation for Treatment-Resistant Depression. Cerebral Cortex. 18(6). 1374–1383. 442 indexed citations
14.
Saxena, Sanjaya, Arthur L. Brody, Karron M. Maidment, et al.. (2004). Cerebral Glucose Metabolism in Obsessive-Compulsive Hoarding. American Journal of Psychiatry. 161(6). 1038–1048. 251 indexed citations
15.
Vroulis, George, Robert C. Smith, Joseph C. Schoolar, et al.. (1982). Reduction of cholesterol risk factors by lecithin in patients with Alzheimer's disease. American Journal of Psychiatry. 139(12). 1633–1634. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026